{"id":"https://openalex.org/W2344949585","doi":"https://doi.org/10.1093/ofid/ofv133.675","title":"Relapsing Clostridium difficile Associated Disease Followed by a Registry and Fecal Microbiota Transplant Attitudes Questionnaire","display_name":"Relapsing Clostridium difficile Associated Disease Followed by a Registry and Fecal Microbiota Transplant Attitudes Questionnaire","publication_year":2015,"publication_date":"2015-01-01","ids":{"openalex":"https://openalex.org/W2344949585","doi":"https://doi.org/10.1093/ofid/ofv133.675","mag":"2344949585"},"language":"en","primary_location":{"id":"doi:10.1093/ofid/ofv133.675","doi":"https://doi.org/10.1093/ofid/ofv133.675","is_oa":true,"landing_page_url":"https://doi.org/10.1093/ofid/ofv133.675","pdf_url":null,"source":{"id":"https://openalex.org/S2735126445","display_name":"Open Forum Infectious Diseases","issn_l":"2328-8957","issn":["2328-8957"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Open Forum Infectious Diseases","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1093/ofid/ofv133.675","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5039425141","display_name":"Alfred E. Bacon","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alfred E. Bacon","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082916766","display_name":"Danielle L. Mosby","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Danielle Mosby","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073975498","display_name":"Claudine T. Jurkovitz","orcid":"https://orcid.org/0000-0002-8957-0100","observed_orcids":["https://orcid.org/0000-0002-8957-0100"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Claudine Jurkovitz","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087799056","display_name":"Bailey Ingraham Lopresto","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Bailey Ingraham Lopresto","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086662146","display_name":"Marci L. Drees","orcid":"https://orcid.org/0000-0002-1504-3615","observed_orcids":["https://orcid.org/0000-0002-1504-3615"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Marci Drees","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045737623","display_name":"Anand P. Panwalker","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Anand Panwalker","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5010202634","display_name":"Patty McGraw","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Patty Mcgraw","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4053,"currency":"USD","value_usd":4053},"apc_paid":{"value":4053,"currency":"USD","value_usd":4053},"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.19836401,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"2","issue":"suppl_1","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11288","display_name":"Clostridium difficile and Clostridium perfringens research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11288","display_name":"Clostridium difficile and Clostridium perfringens research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10066","display_name":"Gut microbiota and health","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12167","display_name":"Bacterial Identification and Susceptibility Testing","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1308","display_name":"Clinical Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/clostridium-difficile-associated-disease","display_name":"Clostridium difficile-associated disease","score":0.9380000233650208},{"id":"https://openalex.org/keywords/relapse","display_name":"relapse","score":0.7549999952316284},{"id":"https://openalex.org/keywords/fecal-microbiota-transplantation","display_name":"fecal microbiota transplantation","score":0.9200000166893005},{"id":"https://openalex.org/keywords/nosocomial-infections","display_name":"nosocomial infections","score":0.8080000281333923},{"id":"https://openalex.org/keywords/vancomycin","display_name":"vancomycin","score":0.8240000009536743},{"id":"https://openalex.org/keywords/metronidazole","display_name":"metronidazole","score":0.9990000128746033},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.6320000290870667},{"id":"https://openalex.org/keywords/fidaxomicin","display_name":"fidaxomicin","score":0.7639999985694885},{"id":"https://openalex.org/keywords/rifaximin","display_name":"rifaximin","score":0.9440000057220459},{"id":"https://openalex.org/keywords/probiotics","display_name":"probiotics","score":0.972000002861023},{"id":"https://openalex.org/keywords/mortality","display_name":"mortality","score":0.4259999990463257},{"id":"https://openalex.org/keywords/patient-registry","display_name":"patient registry","score":0.4309999942779541},{"id":"https://openalex.org/keywords/treatment-patterns","display_name":"treatment patterns","score":0.38199999928474426},{"id":"https://openalex.org/keywords/critically-ill-patients","display_name":"critically ill patients","score":0.7599999904632568},{"id":"https://openalex.org/keywords/adjunctive-therapy","display_name":"adjunctive therapy","score":0.503000020980835},{"id":"https://openalex.org/keywords/quality-of-life","display_name":"quality of life","score":0.3889999985694885}],"concepts":[{"id":"https://openalex.org/C2994496256","wikidata":"https://www.wikidata.org/wiki/Q27031090","display_name":"Clostridium difficile","level":3,"score":0.8861125111579895},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8744214773178101},{"id":"https://openalex.org/C137923570","wikidata":"https://www.wikidata.org/wiki/Q2121103","display_name":"Fecal bacteriotherapy","level":4,"score":0.7736417055130005},{"id":"https://openalex.org/C61716771","wikidata":"https://www.wikidata.org/wiki/Q496","display_name":"Feces","level":2,"score":0.5605655908584595},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.44576916098594666},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.4440039098262787},{"id":"https://openalex.org/C512399662","wikidata":"https://www.wikidata.org/wiki/Q3505712","display_name":"Family medicine","level":1,"score":0.3471466898918152},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.307491660118103},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.13903337717056274},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.06766271591186523}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1093/ofid/ofv133.675","doi":"https://doi.org/10.1093/ofid/ofv133.675","is_oa":true,"landing_page_url":"https://doi.org/10.1093/ofid/ofv133.675","pdf_url":null,"source":{"id":"https://openalex.org/S2735126445","display_name":"Open Forum Infectious Diseases","issn_l":"2328-8957","issn":["2328-8957"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Open Forum Infectious Diseases","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1093/ofid/ofv133.675","doi":"https://doi.org/10.1093/ofid/ofv133.675","is_oa":true,"landing_page_url":"https://doi.org/10.1093/ofid/ofv133.675","pdf_url":null,"source":{"id":"https://openalex.org/S2735126445","display_name":"Open Forum Infectious Diseases","issn_l":"2328-8957","issn":["2328-8957"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Open Forum Infectious Diseases","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2982006247","https://openalex.org/W3093939991","https://openalex.org/W2563627394","https://openalex.org/W2336084667","https://openalex.org/W2588553535","https://openalex.org/W2776108122","https://openalex.org/W3214141520","https://openalex.org/W2340710426","https://openalex.org/W2979015453","https://openalex.org/W7163660378"],"abstract_inverted_index":{"Background.":[0],"Management":[1],"of":[2,30,63,190,209,224,227,231,247,255,257,267,284,296,305,323],"Clostridium":[3],"difficile":[4],"associated":[5],"disease":[6,201,204],"(CDAD)":[7],"moving":[8],"forward":[9],"requires":[10],"clear":[11],"data":[12,49],"delineating":[13],"the":[14,28,70,248,276],"treatment":[15,170,331],"and":[16,27,56,77,98,114,148,155,178,226,252,272],"outcomes":[17],"related":[18],"to":[19,126,143,287],"current":[20],"practices.":[21],"With":[22],"this":[23],"critically":[24],"ill":[25],"population":[26,308],"advent":[29],"new":[31],"agents":[32],"including":[33],"fecal":[34],"microbiota":[35],"transplant":[36],"(FMT),":[37],"we":[38,57],"must":[39],"determine":[40,144],"where":[41],"these":[42],"interventions":[43],"shoud":[44],"be":[45],"utilized.":[46],"CDAD":[47,66,145,278,307,324],"registry":[48,71],"was":[50,167,196,221],"previously":[51],"reported":[52,338],"after":[53],"six":[54],"months,":[55],"now":[58],"report":[59],"our":[60,292,306],"one-year":[61],"follow-up":[62],"hospital":[64,316],"acquired":[65],"patients":[67,103,152,210,233,258,325],"enrolled":[68,250],"in":[69,85,199,216,245,275],"describing":[72],"treatment,":[73],"relapse,":[74],"adjunctive":[75],"therapy":[76,195],"attitudes":[78],"toward":[79,241],"FMT.":[80],"Methods.":[81],"Prospective":[82],"observational":[83],"study":[84],"an":[86],"1100":[87],"bed":[88],"academic":[89],"community":[90],"health":[91],"system.":[92],"Patient":[93],"enrollment":[94],"between":[95],"April":[96,99],"2013":[97],"2014":[100],"included":[101,171],"hospitalized":[102],">18":[104],"years,":[105],"having":[106],"a":[107,115,160,235],"first":[108],"episode":[109],"CDAD,":[110],">3":[111],"stools/24":[112],"hours":[113],"positive":[116],"stool":[117],"assay.":[118],"Patients":[119],"were":[120,124,135,153,157,185,243],"excluded":[121],"if":[122,262,332],"there":[123],"barriers":[125],"follow":[127],"up":[128],"or":[129,183],"anticipated":[130],"<6-month":[131],"survival.":[132],"Telephone":[133],"interviews":[134],"conducted":[136],"weekly":[137],"then":[138],"monthly":[139],"for":[140,159,187,311],"1":[141],"year":[142],"activity,":[146],"wellness,":[147],"attitudes.":[149],"Results.":[150],"158":[151,249],"enrolled,":[154],"113":[156],"followed":[158],"full":[161],"12":[162],"months.":[163],"The":[164,265],"all-cause":[165],"mortality":[166],"16%.":[168],"Initial":[169],"vancomycin":[172],"(V)":[173],"19%,":[174],"metronidazole":[175],"(M)":[176],"55%,":[177],"combination":[179,194,268],"(VM)":[180],"24%.":[181],"Rifaximin":[182],"fidaxomicin":[184],"used":[186,274],"only":[188],"2%":[189],"patients.":[191],"Treatment":[192],"with":[193],"more":[197],"common":[198],"moderate/severe":[200],"than":[202,302],"mild":[203],"(28%":[205],"versus":[206],"13%).":[207],"43%":[208],"received":[211],"probiotics":[212],"at":[213],"some":[214],"point":[215],"care.":[217],"Primary":[218],"relapse":[219,237,282,294],"rate":[220,283,295],"20%":[222,285],"(23":[223],"113),":[225],"those,":[228],"22%":[229,297],"(5":[230],"23)":[232],"had":[234],"second":[236],"(overall":[238],"4%).":[239],"Attitudes":[240],"FMT":[242,261,312,329],"assessed":[244],"92":[246],"patients,":[251],"52%":[253],"(48":[254],"92)":[256],"would":[259,327],"accept":[260,328],"offered.":[263,333],"Conclusion.":[264],"use":[266],"vancomycin/metronidazole":[269],"is":[270,300],"high":[271,321],"increasingly":[273],"severe":[277],"patient.":[279],"Our":[280],"primary":[281],"appears":[286],"fit":[288],"prior":[289],"studies;":[290],"however,":[291],"secondary":[293],"(4%":[298],"overall)":[299],"lower":[301],"expected.":[303],"4%":[304],"are":[309],"candidates":[310],"based":[313],"on":[314],"strict":[315],"criteria":[317],"(2":[318],"relapses).":[319],"A":[320],"percentage":[322],"(52%)":[326],"as":[330],"Disclosures.":[334],"All":[335],"authors:":[336],"No":[337],"disclosures.":[339]},"counts_by_year":[],"updated_date":"2026-09-26T08:19:03.415552","created_date":"2016-06-24T00:00:00"}